SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.1218
+0.0048 (4.10%)
At close: May 13, 2026
SoftOx Solutions AS Market Cap
SoftOx Solutions AS has a market cap or net worth of 311.25 million as of May 14, 2026. Its market cap has increased by 33.58% in one year.
Market Cap
311.25M
Enterprise Value
291.46M
Revenue
15.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since June 1, 2018, SoftOx Solutions AS's market cap has increased from 124.04M to 311.25M, an increase of 150.94%. That is a compound annual growth rate of 12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 311.25M | 48.30% |
| Dec 30, 2025 | 209.88M | 668.29% |
| Dec 30, 2024 | 27.32M | -18.48% |
| Dec 29, 2023 | 33.51M | -86.09% |
| Dec 30, 2022 | 240.99M | -57.32% |
| Dec 30, 2021 | 564.67M | -7.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.36B |
| Thor Medical ASA | 1.62B |
| Nykode Therapeutics AS | 1.02B |
| ArcticZymes Technologies ASA | 1.01B |
| Lytix Biopharma ASA | 807.45M |
| Zelluna ASA | 562.17M |
| Oncoinvent ASA | 202.87M |
| Arctic Bioscience AS | 92.46M |